Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance

A benzene-poly-carboxylic acid complex with cis-diammineplatinum(II) dihydrocholride, BP-C1 is currently used in clinical trials in treating metastatic breast cancer. BP-C1 controls tumor growth with a few mild side-effects, improving quality of life. METHODS: The data consisted of prospectively col...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindkær-Jensen, Steen, Larsen, Stig, Habib-Lindkær-Jensen, Nina, Fagertun, Hans E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364592/
https://www.ncbi.nlm.nih.gov/pubmed/25792808
http://dx.doi.org/10.2147/DDDT.S80451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364592/
https://www.ncbi.nlm.nih.gov/pubmed/25792808
http://dx.doi.org/10.2147/DDDT.S80451

Ejemplares similares